CVS Health Corporation announced its first quarter 2025 results, showing a significant increase in GAAP diluted EPS from $0.88 to $1.41 and Adjusted EPS from $1.31 to $2.25 compared to the prior year. This growth is attributed to improved operating results in the Health Care Benefits segment, reflecting favorable prior-year developments and enhanced performance in Medicare, including the impact of improved Medicare Advantage star ratings for the 2025 payment year. The company also updated its full-year 2025 guidance, reflecting strong performance across all businesses while remaining cautious due to ongoing cost trends and potential macroeconomic challenges.
— new from CVS Health